Literature DB >> 17243908

Linking laboratory and medication data: new opportunities for pharmacoepidemiological research.

Maarten J ten Berg1, Albert Huisman, Patricia M L A van den Bemt, Alfred F A M Schobben, Antoine C G Egberts, Wouter W van Solinge.   

Abstract

Transfer of automated laboratory data collected during routine clinical care from the laboratory information system into a database format that enables linkage to other administrative (e.g., patient characteristics) or clinical (e.g., medication, diagnoses, procedures) data provides a valuable tool for clinical epidemiological research. It allows the investigation of biochemical characteristics of diseases, therapeutic effects and diagnostic and/or prognostic markers for disease with easy access and at relatively low cost. To this end, the Utrecht Patient Oriented Database (UPOD), an infrastructure of relational databases comprising data on patient characteristics, laboratory test results, medication orders, hospital discharge diagnoses and medical procedures for all patients treated at the University Medical Centre Utrecht since January 2004, was established. Current research within UPOD is focused on the innovative linkage of laboratory and medication data, which, for example, makes it possible to assess the quality of pharmacotherapy in clinical practice, to investigate interference between laboratory tests and drugs, to study the risk of adverse drug reactions, and to develop diagnostic and prognostic markers or algorithms for adverse drug reactions. Although recently established, we believe that UPOD broadens the opportunities for clinical pharmacoepidemiological research and can contribute to patient care from a laboratory perspective.

Entities:  

Mesh:

Year:  2007        PMID: 17243908     DOI: 10.1515/CCLM.2007.009

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  47 in total

1.  Thrombocytopenia in adult cancer patients receiving cytotoxic chemotherapy: results from a retrospective hospital-based cohort study.

Authors:  Maarten J Ten Berg; Patricia M L A van den Bemt; Sumitra Shantakumar; Dimitri Bennett; Emile E Voest; Albert Huisman; Wouter W van Solinge; Toine C G Egberts
Journal:  Drug Saf       Date:  2011-12-01       Impact factor: 5.606

2.  Seasonal changes in gene expression represent cell-type composition in whole blood.

Authors:  Simone De Jong; Marjolein Neeleman; Jurjen J Luykx; Maarten J ten Berg; Eric Strengman; Hanneke H Den Breeijen; Leon C Stijvers; Jacobine E Buizer-Voskamp; Steven C Bakker; René S Kahn; Steve Horvath; Wouter W Van Solinge; Roel A Ophoff
Journal:  Hum Mol Genet       Date:  2014-01-07       Impact factor: 6.150

3.  Frequency and nature of drug-drug interactions in a Dutch university hospital.

Authors:  Jeannette E F Zwart-van Rijkom; Esther V Uijtendaal; Maarten J ten Berg; Wouter W van Solinge; Antoine C G Egberts
Journal:  Br J Clin Pharmacol       Date:  2009-08       Impact factor: 4.335

4.  Nonlinear protein binding of phenytoin in clinical practice: Development and validation of a mechanistic prediction model.

Authors:  Rob Ter Heine; Sean P Kane; Alwin D R Huitema; Matthew D Krasowski; Erik M van Maarseveen
Journal:  Br J Clin Pharmacol       Date:  2019-08-07       Impact factor: 4.335

5.  Development of a nomogram for the estimation of long-term adherence to clozapine therapy using neutrophil fluorescence.

Authors:  W H Man; A Pérez-Pitarch; I Wilting; E R Heerdink; W W van Solinge; A C G Egberts; A D R Huitema
Journal:  Br J Clin Pharmacol       Date:  2018-04-02       Impact factor: 4.335

6.  Facilitating Clinical Research through the Health Information Exchange: Lipid Control as an Example.

Authors:  Vivienne J Zhu; Wanzhu Tu; Marc B Rosenman; J Marc Overhage
Journal:  AMIA Annu Symp Proc       Date:  2010-11-13

7.  Lower Platelet Reactivity Is Associated with Presentation of Unstable Coronary Artery Disease.

Authors:  Tesse C Leunissen; Crystel M Gijsberts; Peter Paul Wisman; Albert Huisman; Maarten Ten Berg; Folkert W Asselbergs; Imo E Hoefer; Gerard Pasterkamp; Frans L Moll; Gert Jan de Borst; Mark Roest
Journal:  Int J Angiol       Date:  2016-10-24

8.  Testing bias in clinical databases: methodological considerations.

Authors:  Karin J Velthove; Hubert Gm Leufkens; Patrick C Souverein; René C Schweizer; Wouter W van Solinge
Journal:  Emerg Themes Epidemiol       Date:  2010-05-14

9.  Factors associated with ordering laboratory monitoring of high-risk medications.

Authors:  Shira H Fischer; Jennifer Tjia; George Reed; Daniel Peterson; Jerry H Gurwitz; Terry S Field
Journal:  J Gen Intern Med       Date:  2014-06-26       Impact factor: 5.128

10.  Platelet measurements versus discharge diagnoses for identification of patients with potential drug-induced thrombocytopenia: a cross-sectional study in the Netherlands.

Authors:  Maarten J ten Berg; Wouter W van Solinge; Patricia M L A van den Bemt; Albert Huisman; Alfred F A M Schobben; Toine C G Egberts
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.